ID23150A - ANTITUMOR ACTIVITY STRENGTHENING METHODS OF FATH MEDICINE, COMPOSITION WHICH CONTAINS GUBAL ABAT, ACTIVITIES OF ANTITUMOR ACTIVITIES, UTK METHOD FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN COMPOSITION CONTAINING GUBAL ABAT FOR ANTITUMOR ACTIVITY STRENGTHENING, METHODS FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANALYSIS OF ANTITUMOR ACTIVITIES, METHODS OF UTK TO EVALUATE THE PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANTITUMOR ACTIVITIES, THE METHOD OF UTK TO EVALUATE THE PREGNANCY OF DOCUMENTAL MEDICATION - Google Patents

ANTITUMOR ACTIVITY STRENGTHENING METHODS OF FATH MEDICINE, COMPOSITION WHICH CONTAINS GUBAL ABAT, ACTIVITIES OF ANTITUMOR ACTIVITIES, UTK METHOD FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN COMPOSITION CONTAINING GUBAL ABAT FOR ANTITUMOR ACTIVITY STRENGTHENING, METHODS FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANALYSIS OF ANTITUMOR ACTIVITIES, METHODS OF UTK TO EVALUATE THE PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANTITUMOR ACTIVITIES, THE METHOD OF UTK TO EVALUATE THE PREGNANCY OF DOCUMENTAL MEDICATION

Info

Publication number
ID23150A
ID23150A IDP990871D ID990871D ID23150A ID 23150 A ID23150 A ID 23150A ID P990871 D IDP990871 D ID P990871D ID 990871 D ID990871 D ID 990871D ID 23150 A ID23150 A ID 23150A
Authority
ID
Indonesia
Prior art keywords
pregnancy
utk
activities
antitumor
methods
Prior art date
Application number
IDP990871D
Other languages
Indonesian (id)
Inventor
Kozo Niwa
Original Assignee
Kozo Niwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwa filed Critical Kozo Niwa
Publication of ID23150A publication Critical patent/ID23150A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDP990871D 1998-09-17 1999-09-17 ANTITUMOR ACTIVITY STRENGTHENING METHODS OF FATH MEDICINE, COMPOSITION WHICH CONTAINS GUBAL ABAT, ACTIVITIES OF ANTITUMOR ACTIVITIES, UTK METHOD FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN COMPOSITION CONTAINING GUBAL ABAT FOR ANTITUMOR ACTIVITY STRENGTHENING, METHODS FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANALYSIS OF ANTITUMOR ACTIVITIES, METHODS OF UTK TO EVALUATE THE PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANTITUMOR ACTIVITIES, THE METHOD OF UTK TO EVALUATE THE PREGNANCY OF DOCUMENTAL MEDICATION ID23150A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (en) 1998-09-17 1998-11-13 Method of strengthening antitumor activity of crude drug, composition containing crude drug for strengthening antitumor activity, method of evaluating antitumor effectivity treated by crude drug and method of evaluating antitumor effectivity of crud drug

Publications (1)

Publication Number Publication Date
ID23150A true ID23150A (en) 2000-03-23

Family

ID=26546176

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990871D ID23150A (en) 1998-09-17 1999-09-17 ANTITUMOR ACTIVITY STRENGTHENING METHODS OF FATH MEDICINE, COMPOSITION WHICH CONTAINS GUBAL ABAT, ACTIVITIES OF ANTITUMOR ACTIVITIES, UTK METHOD FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN COMPOSITION CONTAINING GUBAL ABAT FOR ANTITUMOR ACTIVITY STRENGTHENING, METHODS FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANALYSIS OF ANTITUMOR ACTIVITIES, METHODS OF UTK TO EVALUATE THE PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANTITUMOR ACTIVITIES, THE METHOD OF UTK TO EVALUATE THE PREGNANCY OF DOCUMENTAL MEDICATION

Country Status (19)

Country Link
JP (1) JP2000159682A (en)
KR (1) KR20000023206A (en)
CN (1) CN1255376A (en)
AU (1) AU4486299A (en)
BE (1) BE1012725A5 (en)
CA (1) CA2282234A1 (en)
DE (1) DE19944695A1 (en)
DK (1) DK199901235A (en)
ES (1) ES2155802B1 (en)
FR (2) FR2783426A1 (en)
GB (2) GB9920710D0 (en)
ID (1) ID23150A (en)
IL (1) IL131722A0 (en)
IS (1) IS5183A (en)
IT (1) IT1307267B1 (en)
NL (2) NL1013049C2 (en)
NO (1) NO994463L (en)
SE (2) SE9903307L (en)
SG (1) SG76631A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100112205A (en) * 2001-04-27 2010-10-18 아지노모토 가부시키가이샤 Immunopotentiators
CN1320121C (en) * 2001-05-07 2007-06-06 拜奥哈步株式会社 Method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (en) * 2001-05-21 2010-07-14 コンビ株式会社 Composition for controlling pathogen infection
JP4561098B2 (en) * 2001-06-01 2010-10-13 味の素株式会社 Diabetes medicine
JP4826696B2 (en) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 Angiogenesis inhibitors
JP4681801B2 (en) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 Angiogenesis inhibitor and method for producing the same
US7977379B2 (en) 2002-05-15 2011-07-12 Bhn Co., Ltd. Method for angiogenesis inhibition or immunostimulation
JP2005089417A (en) * 2003-09-19 2005-04-07 Noevir Co Ltd Composition for prevention/treatment of diabetes
JP4587441B2 (en) * 2004-02-12 2010-11-24 株式会社クレハ Novel diabetes treatment and food
US8034386B2 (en) 2004-09-17 2011-10-11 Ssi Co., Ltd. Extract from Agaricus blazei Murill capable of suppressing breast cancer
JP2006273835A (en) * 2005-03-04 2006-10-12 Michishi Tani Therapeutic agent for malignant tumor and food or beverage containing the same
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee
WO2011081024A1 (en) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 Umami food, and method for producing same
CN106333969A (en) * 2016-08-30 2017-01-18 青海民族大学 Agaricus gennadii HDAC1 enzyme inhibition effective part and preparation method and application
CN106309511A (en) * 2016-08-30 2017-01-11 青海民族大学 Effective part of agaricus gennadii for inhibiting CDC25 enzyme as well as preparation method and application of effective part
US20200397817A1 (en) * 2017-11-30 2020-12-24 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102646421B1 (en) * 2020-12-16 2024-03-12 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Grifola frondosa
KR102602787B1 (en) * 2020-12-16 2023-11-17 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Sparassis crispa
KR102584680B1 (en) * 2020-12-17 2023-10-06 대한민국 Method for manufacturing tea of Lentinula edodes tea improved physiological activities and nutrition components

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (en) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (en) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd Food having antitumor function and production thereof
JP3357383B2 (en) * 1991-08-14 2002-12-16 昌宏 黒田 Low molecular weight plant composition
JP2955126B2 (en) * 1992-06-22 1999-10-04 笑代 丹羽 Pharmaceutical oleaginous preparation, food oleaginous preparation and production method thereof
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
ITTO990784A0 (en) 1999-09-14
SG76631A1 (en) 2000-11-21
JP2000159682A (en) 2000-06-13
NO994463L (en) 2000-03-20
AU4486299A (en) 2000-03-30
FR2783426A1 (en) 2000-03-24
DK199901235A (en) 2000-03-18
ES2155802A1 (en) 2001-05-16
NL1019705A1 (en) 2002-01-29
SE0100195D0 (en) 2001-01-24
BE1012725A5 (en) 2001-02-06
KR20000023206A (en) 2000-04-25
FR2788697A1 (en) 2000-07-28
GB9921387D0 (en) 1999-11-10
NL1013049A1 (en) 2000-03-21
NL1013049C2 (en) 2002-01-11
SE0100195L (en) 2001-01-24
NO994463D0 (en) 1999-09-15
DE19944695A1 (en) 2000-03-30
CN1255376A (en) 2000-06-07
GB9920710D0 (en) 1999-11-03
NL1019705C2 (en) 2002-03-26
IT1307267B1 (en) 2001-10-30
SE9903307D0 (en) 1999-09-16
IL131722A0 (en) 2001-03-19
SE9903307L (en) 2000-03-18
ITTO990784A1 (en) 2001-03-14
ES2155802B1 (en) 2001-12-01
IS5183A (en) 2000-03-17
GB2341800A (en) 2000-03-29
CA2282234A1 (en) 2000-03-17

Similar Documents

Publication Publication Date Title
ID23150A (en) ANTITUMOR ACTIVITY STRENGTHENING METHODS OF FATH MEDICINE, COMPOSITION WHICH CONTAINS GUBAL ABAT, ACTIVITIES OF ANTITUMOR ACTIVITIES, UTK METHOD FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN COMPOSITION CONTAINING GUBAL ABAT FOR ANTITUMOR ACTIVITY STRENGTHENING, METHODS FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANALYSIS OF ANTITUMOR ACTIVITIES, METHODS OF UTK TO EVALUATE THE PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANTITUMOR ACTIVITIES, THE METHOD OF UTK TO EVALUATE THE PREGNANCY OF DOCUMENTAL MEDICATION
EA200000814A1 (en) PHARMACEUTICAL COMPOSITION TOPIRAMAT
HUP0301046A3 (en) Quinazoline derivatives for the treatment of tumours, process for their preparation and pharmaceutical compositions containing them
HUP0402588A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, process for producing them and their use
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
FR2816938B1 (en) 3-AROYLINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26435A1 (en) AMIDO-SUBSTITUTED BENZYLAMINE DERIVATIVES, THEIR PRECURSOR DERIVATIVES FOR MEDICAMENTS, THEIR PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND TREATMENT METHOD USING THE SAME.
MA27410A1 (en) NOVEL PYRIDOPYRIMIDINONE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA24484A1 (en) ATROPISOMERS OF 3-ARYL-4 (3H) -QUINAZOLINONES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.
PL393385A1 (en) Method for modification and habit recrystallization of drug substance, mycophenolate sodium crystals, the use thereof and pharmaceutical composition
HK1075450A1 (en) heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine
HUP0105313A3 (en) Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
HK1076095A1 (en) Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
AU2002226690A1 (en) Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
MA27147A1 (en) SUBSTITUTED 4-PHENYLTETRAHYDRO-ISOQUINOLEINS, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS, AND MEDICAMENTS CONTAINING THEM
EG24784A (en) Isoindolone derivatives, preparation process and intermediates of this process, their use as medicaments and pharmaceutical comprising them.
DE60202603D1 (en) 8- (C-BETA-D-GLUCOPYRANOSYL) -7,3 ', 4'-TRIHYDROXYFLAVONE, METHOD FOR THE ISOLATION OF PTEROCARPUS MARSUPIUM AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
AU2002309083A1 (en) Method for identifying drugs for the treatment of type ii diabetes
WO2002067771A3 (en) Chemokine receptors and disease
HUP0104002A3 (en) Alpha2-antagonists tricyclic delta3-piperidines, process for their producing the pharmaceutical compositions containing them and their use as medicament
FR2845388B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2791980B1 (en) PYRIDO-THIENO-DIAZEPINES, THEIR PREPARATION PROCESS, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP1532979A4 (en) Drug composition for blood sugar control
AU8893098A (en) Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting